1. Home
  2. SFHG vs BIAF Comparison

SFHG vs BIAF Comparison

Compare SFHG & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Samfine Creation Holdings Group Limited Ordinary Share

SFHG

Samfine Creation Holdings Group Limited Ordinary Share

HOLD

Current Price

$2.13

Market Cap

9.5M

ML Signal

HOLD

Logo bioAffinity Technologies Inc.

BIAF

bioAffinity Technologies Inc.

HOLD

Current Price

$3.86

Market Cap

9.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SFHG
BIAF
Founded
1993
2014
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Publishing
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5M
9.2M
IPO Year
2022
2022

Fundamental Metrics

Financial Performance
Metric
SFHG
BIAF
Price
$2.13
$3.86
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.3K
★ 3.1M
Earning Date
10-29-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $7,900,000.00
Revenue This Year
N/A
$18.58
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 14.49
52 Week Low
$0.32
$0.37
52 Week High
$3.17
$21.52

Technical Indicators

Market Signals
Indicator
SFHG
BIAF
Relative Strength Index (RSI) 43.91 37.19
Support Level $1.95 $3.31
Resistance Level $2.56 $4.35
Average True Range (ATR) 0.06 0.83
MACD -0.01 -0.49
Stochastic Oscillator 21.88 2.31

Price Performance

Historical Comparison
SFHG
BIAF

About SFHG Samfine Creation Holdings Group Limited Ordinary Share

Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc develops noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial intelligence (AI). Its first commercial diagnostic test, CyPath Lung, identifies and analyzes cell populations using flow cytometry, including cancer and cancer-related cells, that indicate a malignancy in the lung. It is developing its flow cytometry platform to address the need to identify patients who can benefit from new and emerging therapies for asthma and chronic obstructive pulmonary disease with noninvasive precision diagnostic tests. The company is organized in two operating segments, Diagnostic Research and Development and Laboratory Services.

Share on Social Networks: